Xcout Intel
LifeMine Therapeutics, Inc.
LifeMine Therapeutics is a privately held biotechnology company founded in 2017 with headquarters in Watertown, Massachusetts, and an additional location in Switzerland. The company leverages genomic data to accelerate the discovery and development of novel small-molecule medicines.
Subscribe to see LifeMine Therapeutics, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
LifeMine Therapeutics, Inc. at a glance
LifeMine Therapeutics, Inc. is a biotechnology company headquartered in United States. It has raised at least $388.1M across the 5 funding rounds on record. Its most recent funding round, Series E, raised $188M in August 2026. Xcout tracks 1 named person at LifeMine Therapeutics, Inc., including Gregory Verdine, PhD (CEO). Xcout recorded 3 job postings from LifeMine Therapeutics, Inc. in the last 90 days.
LifeMine Therapeutics, Inc. leadership
- Gregory Verdine, PhDCEO
LifeMine Therapeutics, Inc. funding rounds
At least $388.1M raised across the 5 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series E | $188M | 3 named | |
| Series D | $75M | 2 named | |
| — | $50M | 3 named | |
| SEC Form D filing | $70.1M | — | |
| SEC Form D filing | $5M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Hiring at LifeMine Therapeutics, Inc.
Xcout recorded 3 job postings from LifeMine Therapeutics, Inc. in the last 90 days, from a hiring record Xcout has kept since July 2026.
The weekly hiring trend, the roles and locations behind it — see LifeMine Therapeutics, Inc.'s hiring signals →
Investors
LifeMine Therapeutics, Inc. competitors
A few of LifeMine Therapeutics, Inc.'s closest competitors — see the full list of competitors and alternatives →
Cime Therapeutics Inc. is a chemistry-first company that provides an automated synthesis platform integrating artificial intelligence and machine learning for drug discovery. The company serves the pharmaceutical and biotechnology sectors by producing novel therapeutic molecules, such as small molecules, molecular glues, and covalent compounds, at high speed and scale.
Expedition Medicines, Inc. is a biotechnology company founded in 2022 and headquartered in Cambridge, Massachusetts, focused on generatively designing novel drugs targeting specific proteins.
Matchpoint Therapeutics is a privately held biotechnology company based in Watertown, Massachusetts, focused on advancing a pipeline of first-in-class oral small molecules for autoimmune and inflammatory diseases.
Remix Therapeutics, Inc. is a biotechnology company headquartered in Watertown, Massachusetts. The company specializes in developing novel therapies that alter RNA processing to address serious diseases.
Superluminal Medicines is a generative biology and chemistry company headquartered in Boston, Massachusetts, focused on drug discovery and development.
Variant Bio, Inc. is a biotechnology company that uses human genomic diversity and population genetics to discover therapeutic targets and develop medicines. It works with researchers, healthcare and biotechnology partners, and genetically diverse communities to study traits associated with health and disease.
Get LifeMine Therapeutics, Inc.'s news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Something wrong or missing about LifeMine Therapeutics, Inc.? Suggest a correction
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on LifeMine Therapeutics, Inc. in Xcout Intel
- 1 named person with titles, LinkedIn and board committees
- 5 funding rounds with the investors in each, and who they co-invest with
- Weekly hiring history and the mix of roles behind it
- The full competitor set, tracking, exports and API access